Maximilien Schmitt

Advising PAI Partners on the sale of ELITech Group, global manufacturer of in-vitro diagnostics instruments and reagents, valued at €870 millions, to Bruker Corporation

Advising the Bourbon Group on the tax aspects of the restructuring of €3 billion in equity and debt

Advising the founders of DriiveMe, Europe's market leader in individual vehicle logistics, on the occasion of the acquisition of a minority stake by Isai 

Advising IDI on the acquisition of majority stake in Prevost Laboratory Concept

Advising Shiro Games and its Founders on the acquisition of a stake in the company by Cathay Capital  

Advising on the acquisition of a new 6,600 square metre building in Paris

Advising Andera Partners and the management of the ACB Group on the sale of the Group to Arkéa Capital, Société Générale CP and BNP Paribas Développement.

Avising the Founders and shareholders of Nutravalia, a French laboratory specialising in food supplements and parapharmaceutical products, in connection with Capza's investment into its capital.

Advising Activa Capital on its acquisition of a minority stake in BSK Immobilier.

Advising Group REEL, an independent international industrial group, for the takeover of CNIM Group's Industrial Systems business as part of the receivership proceedings of CNIM Groupe.

Advising IDI on the sale of the Winncare Group to Siparex ETI and IDI's subsequent reinvestment into the Group.